LEXINGTON, Mass.--(BUSINESS WIRE)--GI Dynamics, a company pioneering devices to improve glycemic control in patients with type 2 diabetes and achieve weight loss in obese patients, today announced that new data on its EndoBarrier™ platform will be presented at the upcoming SAGES and ECO meetings. Results of preclinical studies on the new EndoBarrier Flow Restrictor, a modified version of the EndoBarrier Gastrointestinal Liner, designed to slow the rate at which the stomach empties, will be presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2009 Annual Meeting in Phoenix, Arizona.
